Search
Achieve Life Sciences Inc
ACHVAdd to Watchlist
6.100USD
-0.070-1.13%
Close 07-24 16:00（ET）Quotes delayed by 15 min
324.77MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-24The current earnings forecast score of Achieve Life Sciences Inc is 8.22, ranking 148 out of 386 in the Biotechnology & Medical Research industry. The average price target is 14.00, with a high of 25.00 and a low of 10.00.
Analyst Rating
Based on
9
analysts
Buy
Current Rating
13.700
Target Price
+122.04%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Achieve Life Sciences Inc
ACHV
9
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Achieve Life Sciences Inc's price target?
Analysts forecast that Achieve Life Sciences Inc's price target is USD 14.00, with the highest forecast at USD 25.00 and the lowest forecast at USD 10.00.
How have Achieve Life Sciences IncACHV's recent earnings per share performed?
The market expectation was USD -0.19, while Achieve Life Sciences IncACHV's earnings per share (EPS) for the previous quarter was USD -0.27. EPS for the next quarter is expected at USD -0.16.
What is the analyst rating for Achieve Life Sciences Inc?
Based on the ratings of Achieve Life Sciences Inc's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.